Microarray Analysis Identifies an Expression Signature for Inflammatory Breast Cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-94-007-3907-9_19
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• High-Resolution Comparative Genomic Hybridization of Inflammatory Breast Cancer and Identification of Candidate Genes

  2011cited by this paper
• Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

  2011cited by this paper
• Gene expression profiling of inflammatory breast cancer

  2010cited by this paper
• Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer

  2010cited by this paper
• The role of molecular analysis in breast cancer

  2009cited by this paper
• Inflammatory breast cancer.

  2009cited by this paper
• Inflammatory breast cancer cells are constitutively adapted to hypoxia

  2009cited by this paper
• Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array

  2009cited by this paper
• Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer

  2009cited by this paper
• Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

  2008cited by this paper
• Defining the clinical diagnosis of inflammatory breast cancer.

  2008cited by this paper
• A stromal gene signature associated with inflammatory breast cancer

  2008cited by this paper
• Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates E-cadherin in the breast epithelium through induction of snail and ZEB1.

  2008cited by this paper
• The medical treatment of inflammatory breast cancer.

  2008cited by this paper
• Defining the molecular biology of inflammatory breast cancer.

  2008cited by this paper
• Molecular determinants of the inflammatory breast cancer phenotype.

  2008cited by this paper
• Integrated profiling of basal and luminal breast cancers.

  2007cited by this paper
• Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis

  2007cited by this paper
• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  2007cited by this paper
• Breast tumor copy number aberration phenotypes and genomic instability

  2006cited by this paper
• A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers

  2006cited by this paper
• Novel patterns of genome rearrangement and their association with survival in breast cancer.

  2006cited by this paper
• Proteomics of Breast Cancer

  2006cited by this paper
• Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

  2006cited by this paper
• Array-CGH and breast cancer

  2006cited by this paper
• Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy

  2006cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype

  2006cited by this paper
• Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells

  2005cited by this paper
• Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis

  2005cited by this paper
• Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.

  2005cited by this paper
• RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

  2005cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer

  2004cited by this paper
• WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

  2004cited by this paper
• Molecular Profiling of Inflammatory Breast Cancer

  2004cited by this paper
• Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes

  2004cited by this paper
• RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells

  2004cited by this paper
• Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

  2004cited by this paper
• WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer

  2003cited by this paper
• WISP3 is a novel tumor suppressor gene of inflammatory breast cancer

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma

  2002cited by this paper
• Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability.

  2002cited by this paper
• Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

  2002cited by this paper
• Real-time multiplex PCR assays.

  2001cited by this paper
• RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

  2000cited by this paper
• RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

  2000cited by this paper
• A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

  1999cited by this paper
• High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

  1998cited by this paper
• More powerful procedures for multiple significance testing.

  1990cited by this paper

• No citing papers are available for this paper.